Westlake Omics
Westlake Omics, established in July 2020, is an AI-empowered micro-world data company focused on advancing precision medicine and drug research and development. They leverage technological innovations in proteomics and multimodal big data. The company has partnered with over 100 universities, research institutes, hospitals, and pharmaceutical companies globally and holds multiple national patents and software copyrights. Westlake Omics offers a range of services including Quantitative Proteomics, Modification Proteomics, Multi-omics Analysis, Targeted Quantification, Metabolomics, and AI-empowered Proteomics Data Analysis. Their product suite includes OmniProt™, FAXP™, ThyroProt™, and the Westlake Omics Cloud Platform.
Westlake Omics
Westlake Omics, established in July 2020, is an AI-empowered micro-world data company focused on advancing precision medicine and drug research and development. They leverage technological innovations in proteomics and multimodal big data. The company has partnered with over 100 universities, research institutes, hospitals, and pharmaceutical companies globally and holds multiple national patents and software copyrights. Westlake Omics offers a range of services including Quantitative Proteomics, Modification Proteomics, Multi-omics Analysis, Targeted Quantification, Metabolomics, and AI-empowered Proteomics Data Analysis. Their product suite includes OmniProt™, FAXP™, ThyroProt™, and the Westlake Omics Cloud Platform.